RTW Investments, LP 13D and 13G filings for iTeos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 10:08 am Sale |
2022-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
RTW Investments, LP | 0 0.000% |
-2,353,015 (Position Closed) |
Filing |
| 2022-02-14 08:41 am Sale |
2021-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
RTW Investments, LP | 2,353,015 6.700% |
-409,776 (-14.83%) |
Filing |
| 2021-02-04 12:36 pm Purchase |
2021-01-25 | 13G | iTeos Therapeutics, Inc. ITOS |
RTW Investments, LP | 2,762,791 7.880% |
2,762,791 (New Position) |
Filing |